The study will be conducted globally with up to 60,000 participants Johnson & Johnson and its Janssen Pharmaceutical Companies announced that planning is underway for the company’s Phase 3 ENSEMBLE clinical trial of its SARS-CoV-2 vaccine candidate, Ad26.COV2.S, subject to the analysis of interim data from the Phase 1/2a trial and approval of regulators. Today,…
● By searching treatments, the pharmaceutical industry is increasing the chances of emerging from the humanitarian crisis as soon as possible. August 2020 – While the search for the vaccine relentlessly continues, the industry has decided to increase the chances of ending the coronavirus crisis by seeking treatments for patients with the virus. Through research…
Viruses, parasites and bacteria that cause diseases have always existed, mutated and appeared at different moments of world history. Recent pandemics, including COVID-19, are not new enemies of humankind, however, the way to face them has changed a lot thanks to the work of scientists, doctors and pharmacists. In fact, until the mid-19th century the…
“Vaccines are one of the most powerful tools in the history of public health”, said Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization, addressing all those who have children at their care, “and more children are now being immunized than ever before”, he explained. Nevertheless, child vaccination has declined during the coronavirus crisis. For…
Making decisions during a pandemic is likely the most difficult task for governments nowadays. Those decisions are always backed by science, data, and the identification of vulnerabilities in each region and city. Therefore, technology has become an important and necessary ally during the pandemic. To assist governments in the decision-making process in Colombia, a group…
Pregnancy is a special time filled with emotions and anticipation. For those moms who have lived this moment in the middle of the coronavirus crisis, fear and anxiety might also be recurring emotions. Therefore, it is fundamental to address any doubts that may arise for pregnant women and healthcare professionals specialized in maternity. Even though…
With the purpose of providing sustainable and continuous training programs to the community of patient organizations in Latin America, LAPA started the second phase of its program in Colombia, focused on the evaluation of HTA, with the support of AFIDRO and FIFARMA. Bogotá, July 2020. The Latin American Patient Academy (LAPA) started the high-level training…
The pharmaceutical research industry is committed to the development of an effective COVID-19 pandemic response, which requires the cooperation of a wide number of stakeholders. On Wednesday July 29th the Latin American Federation of the Pharmaceutical Industry (FIFARMA), invited experts from the pharmaceutical research industry to provide an update regarding the efforts to develop a…
Over time, as the world and culture changes, medicine faces new challenges, such as urgently finding a solution for COVID-19. The pharmaceutical industry, as the main sector responsible for creating medicines and vaccines, has to meet the highest standard of ethics and transparency throughout its production chain. This industry requires that all its suppliers, employees…
As the PANDRH CPP Project reaches a milestone, FIFARMA recognizes CECMED’s Director Dr Pérez Cristiá for his role in this successful initiative. The Project The PANDRH Network is an initiative of National Regulatory Authorities (NRAs) in the Region of the Americas and regional industry associations, including FIFARMA. The technical work of the PANDRH Network supports…
